113 related articles for article (PubMed ID: 32572052)
1. Early-onset atrial fibrillation patients show reduced left ventricular ejection fraction and increased atrial fibrosis.
Andreasen L; Bertelsen L; Ghouse J; Lundegaard PR; Ahlberg G; Refsgaard L; Rasmussen TB; Eiskjær H; Haunsø S; Vejlstrup N; Svendsen JH; Olesen MS
Sci Rep; 2020 Jun; 10(1):10039. PubMed ID: 32572052
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance.
Quail M; Grunseich K; Baldassarre LA; Mojibian H; Marieb MA; Cornfeld D; Soufer A; Sinusas AJ; Peters DC
J Cardiovasc Magn Reson; 2019 Jan; 21(1):2. PubMed ID: 30602395
[TBL] [Abstract][Full Text] [Related]
3. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.
Ling LH; Taylor AJ; Ellims AH; Iles LM; McLellan AJ; Lee G; Kumar S; Lee G; Teh A; Medi C; Kaye DM; Kalman JM; Kistler PM
Heart Rhythm; 2013 Sep; 10(9):1334-9. PubMed ID: 23811081
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive multi-index cardiac magnetic resonance-guided assessment of atrial fibrillation substrate prior to ablation: Prediction of long-term outcomes.
Chubb H; Karim R; Mukherjee R; Williams SE; Whitaker J; Harrison J; Niederer SA; Staab W; Gill J; Schaeffter T; Wright M; O'Neill M; Razavi R
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1894-1903. PubMed ID: 31397511
[TBL] [Abstract][Full Text] [Related]
5. Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.
Habibi M; Lima JA; Khurram IM; Zimmerman SL; Zipunnikov V; Fukumoto K; Spragg D; Ashikaga H; Rickard J; Marine JE; Calkins H; Nazarian S
Circ Cardiovasc Imaging; 2015 Feb; 8(2):e002769. PubMed ID: 25652181
[TBL] [Abstract][Full Text] [Related]
6. Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation.
Ahlberg G; Refsgaard L; Lundegaard PR; Andreasen L; Ranthe MF; Linscheid N; Nielsen JB; Melbye M; Haunsø S; Sajadieh A; Camp L; Olesen SP; Rasmussen S; Lundby A; Ellinor PT; Holst AG; Svendsen JH; Olesen MS
Nat Commun; 2018 Oct; 9(1):4316. PubMed ID: 30333491
[TBL] [Abstract][Full Text] [Related]
7. Atrial fibrosis in non-atrial fibrillation individuals and prediction of atrial fibrillation by use of late gadolinium enhancement magnetic resonance imaging.
Siebermair J; Suksaranjit P; McGann CJ; Peterson KA; Kheirkhahan M; Baher AA; Damal K; Wakili R; Marrouche NF; Wilson BD
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):550-556. PubMed ID: 30661270
[TBL] [Abstract][Full Text] [Related]
8. Verification of threshold for image intensity ratio analyses of late gadolinium enhancement magnetic resonance imaging of left atrial fibrosis in 1.5T scans.
Bertelsen L; Alarcón F; Andreasen L; Benito E; Olesen MS; Vejlstrup N; Mont L; Svendsen JH
Int J Cardiovasc Imaging; 2020 Mar; 36(3):513-520. PubMed ID: 31748945
[TBL] [Abstract][Full Text] [Related]
9. Preferential regional distribution of atrial fibrosis in posterior wall around left inferior pulmonary vein as identified by late gadolinium enhancement cardiac magnetic resonance in patients with atrial fibrillation.
Benito EM; Cabanelas N; Nuñez-Garcia M; Alarcón F; Figueras I Ventura RM; Soto-Iglesias D; Guasch E; Prat-Gonzalez S; Perea RJ; Borràs R; Butakoff C; Camara O; Bisbal F; Arbelo E; Tolosana JM; Brugada J; Berruezo A; Mont L
Europace; 2018 Dec; 20(12):1959-1965. PubMed ID: 29860416
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of quantification methods for left arial late gadolinium enhancement based on different references in patients with atrial fibrillation.
Hwang SH; Oh YW; Lee DI; Shim J; Park SW; Kim YH
Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():91-101. PubMed ID: 25367893
[TBL] [Abstract][Full Text] [Related]
11. Cardiac magnetic resonance using late gadolinium enhancement and atrial T1 mapping predicts poor outcome in patients with atrial fibrillation after catheter ablation therapy.
Luetkens JA; Wolpers AC; Beiert T; Kuetting D; Dabir D; Homsi R; Meendermann H; Dayé NA; Knappe V; Karsdal M; Nielsen SH; Genovese F; Stöckigt F; Linhart M; Thomas D; Nickenig G; Schild HH; Schrickel JW; Andrié RP
Sci Rep; 2018 Sep; 8(1):13618. PubMed ID: 30206274
[TBL] [Abstract][Full Text] [Related]
12. Association of left ventricular late gadolinium enhancement with left atrial low voltage areas in patients with atrial fibrillation.
Stegmann C; Jahnke C; Paetsch I; Hilbert S; Arya A; Bollmann A; Hindricks G; Sommer P
Europace; 2018 Oct; 20(10):1606-1611. PubMed ID: 29420707
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional left atrial blood flow characteristics in patients with atrial fibrillation assessed by 4D flow CMR.
Lee DC; Markl M; Ng J; Carr M; Benefield B; Carr JC; Goldberger JJ
Eur Heart J Cardiovasc Imaging; 2016 Nov; 17(11):1259-1268. PubMed ID: 26590397
[TBL] [Abstract][Full Text] [Related]
14. Left Atrial Function in Patients with Titin Cardiomyopathy.
Henkens MTHM; Raafs AG; Vanloon T; Vos JL; Vandenwijngaard A; Brunner HG; Krapels IPC; Knackstedt C; Gerretsen S; Hazebroek MR; Vernooy K; Nijveldt R; Lumens J; Verdonschot JAJ
J Card Fail; 2024 Jan; 30(1):51-60. PubMed ID: 37230314
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of late atrial enhancement by cardiac magnetic resonance imaging in patients with obstructive sleep apnea.
de Oliveira FG; Pinto I; Valdigem B; Senra T; Bertolami A
Sleep Med; 2020 Oct; 74():204-210. PubMed ID: 32861012
[TBL] [Abstract][Full Text] [Related]
16. Tools to differentiate between Filamin C and Titin truncating variant carriers: value of MRI.
Jacobs J; Van Aelst L; Breckpot J; Corveleyn A; Kuiperi C; Dupont M; Heggermont W; De Vadder K; Willems R; Van Cleemput J; Bogaert JG; Robyns T
Eur J Hum Genet; 2023 Nov; 31(11):1323-1332. PubMed ID: 37032351
[TBL] [Abstract][Full Text] [Related]
17. Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study.
Prabhu S; Taylor AJ; Costello BT; Kaye DM; McLellan AJA; Voskoboinik A; Sugumar H; Lockwood SM; Stokes MB; Pathik B; Nalliah CJ; Wong GR; Azzopardi SM; Gutman SJ; Lee G; Layland J; Mariani JA; Ling LH; Kalman JM; Kistler PM
J Am Coll Cardiol; 2017 Oct; 70(16):1949-1961. PubMed ID: 28855115
[TBL] [Abstract][Full Text] [Related]
18. [Structural and Functional Properties of the Left Atrium in Healthy Volunteers and Patients With Atrial Fibrillation: Data of Magnetic Resonance Imaging].
Stukalova OV; Mironova NA; Golitsyn SP; Aparina OP; Parkhomenko DV; Strazdenj EY; Ternovoy SK
Kardiologiia; 2017 Sep; 57(9):5-13. PubMed ID: 29466218
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Fibrosis Detected on Late Gadolinium-Enhanced Cardiac Magnetic Resonance and Re-Entrant Activity Assessed With Electrocardiographic Imaging in Human Persistent Atrial Fibrillation.
Cochet H; Dubois R; Yamashita S; Al Jefairi N; Berte B; Sellal JM; Hooks D; Frontera A; Amraoui S; Zemoura A; Denis A; Derval N; Sacher F; Corneloup O; Latrabe V; Clément-Guinaudeau S; Relan J; Zahid S; Boyle PM; Trayanova NA; Bernus O; Montaudon M; Laurent F; Hocini M; Haïssaguerre M; Jaïs P
JACC Clin Electrophysiol; 2018 Jan; 4(1):17-29. PubMed ID: 29479568
[TBL] [Abstract][Full Text] [Related]
20. The Spatial Distribution of Late Gadolinium Enhancement of Left Atrial Magnetic Resonance Imaging in Patients With Atrial Fibrillation.
Higuchi K; Cates J; Gardner G; Morris A; Burgon NS; Akoum N; Marrouche NF
JACC Clin Electrophysiol; 2018 Jan; 4(1):49-58. PubMed ID: 29600786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
